B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLCO2B1

MOLECULAR TARGET

solute carrier organic anion transporter family member 2B1

UniProt: O94956NCBI Gene: 1130916 compounds

SLCO2B1 (solute carrier organic anion transporter family member 2B1) is targeted by 16 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLCO2B1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dinoprostone1.393
2fisetin1.102
3Genistein1.102
4Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.102
5Quercetin1.102
6Pravastatin1.102
7Ritonavir1.102
8scutellarein1.102
9Atorvastatin0.691
10Alprostadil0.691
11Dinoprost0.691
12Glyburide0.691
13Prostaglandin D20.691
14Rifamycins0.691
15Rifamycins0.691
16Silymarin0.691

About SLCO2B1 as a Drug Target

SLCO2B1 (solute carrier organic anion transporter family member 2B1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 16 compounds with documented SLCO2B1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLCO2B1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.